EFFICACY AND SAFETY OF UPADACITINIB AS AN INDUCTION THERAPY FOR PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE PHASE 2B STUDY U-ACHIEVE

William Sandborn  1     Subrata Ghosh  2     Julian Panés  3     Stefan Schreiber  4     Geert R. D'Haens  5     Satoshi Tanida  6     Jesse Siffledeen  7     Jose Enejosa     Wen Zhou     Ahmed A. Othman     Bidan Huang     Peter D.R. Higgins    
1 University of California San Diego,La Jolla,United States
2 University of Birmingham,Birmingham,United Kingdom
3 Hospital Clínic Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
4 University Hospital Schleswig-Holstein,Kiel,Germany
5 Academic Medical Center,Amsterdam,Netherlands
6 Nagoya City University,Nagoya,Japan
7 University of Alberta,Edm

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing